These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 7025846

  • 21. Long term effect of captopril in hypertension with chronic renal failure.
    Gassia JP, Durand D, Ton That H, Degroc F, Suc JM.
    Proc Eur Dial Transplant Assoc; 1980; 17():719-24. PubMed ID: 7017704
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of severe resistant arterial hypertension with captopril. 58 patients, including 38 treated for more than 6 months (author's transl)].
    Zech PY, Trotta P, Labeeuw M.
    Nouv Presse Med; 1981 Apr 30; 10(19):1571-4. PubMed ID: 7025847
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ, Julius S, Nicholls MG.
    Arch Intern Med; 1981 Jun 30; 141(7):907-10. PubMed ID: 6263204
    [Abstract] [Full Text] [Related]

  • 24. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
    Ermolenko VM, Lifshits NL, Zisel'man SB, Tatsievskiĭ VA.
    Urol Nefrol (Mosk); 1991 Jun 30; (3):41-8. PubMed ID: 1871923
    [Abstract] [Full Text] [Related]

  • 25. [Efficacy of captopril in periarteritis nodosa with arterial hypertension and renal failure (author's transl)].
    Guillevin L, Leenhardt A, Herson S, Bletry O, Godeau P.
    Nouv Presse Med; 1981 Apr 30; 10(19):1592-3. PubMed ID: 6116493
    [Abstract] [Full Text] [Related]

  • 26. [Captopril in severe arterial hypertension of childhood (authors transl)].
    Bacri JL, Dechaux M, André JL, Gagnadoux MF, Broyer M.
    Arch Fr Pediatr; 1981 Dec 30; 38 Suppl 1():887-92. PubMed ID: 7036933
    [Abstract] [Full Text] [Related]

  • 27. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H, Uneda S, Tochikubo O, Ohonishi T, Harada J, Sesoko S, Goto E, Fujishima S, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1980 Jan 30; 22(1):13-22. PubMed ID: 6247528
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of hypertensive crisis with captopril].
    Biollaz J, Waeber B, Turini GA, Schaller MD, Brunner HR.
    Schweiz Med Wochenschr; 1983 Dec 31; 113(52):2006-7. PubMed ID: 6364338
    [Abstract] [Full Text] [Related]

  • 29. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
    Santucci A, Aguglia F, Ficara C.
    Clin Ter; 1981 Apr 15; 97(1):43-58. PubMed ID: 6269793
    [No Abstract] [Full Text] [Related]

  • 30. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A, Caralps A, Rama H, Sarrias X, Alsina J.
    Rev Clin Esp; 1981 Sep 30; 162(6):265-8. PubMed ID: 7036249
    [No Abstract] [Full Text] [Related]

  • 31. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F.
    MMW Munch Med Wochenschr; 1981 Nov 20; 123(47):1803-9. PubMed ID: 6796855
    [Abstract] [Full Text] [Related]

  • 32. [Antihypertensive effect of an oral angiotensin I-converting enzyme inhibitor in two cases with malignant hypertension (author's transl)].
    Mizuno K, Gotho M, Tsutsui K, Yamazaki M, Shigetomi S, Kudo S, Matsui J, Haruyama K, Nakamura I, Toki T, Nagasawa S, Fukuchi S.
    Nihon Jinzo Gakkai Shi; 1981 Jan 20; 23(1):1-12. PubMed ID: 7026848
    [No Abstract] [Full Text] [Related]

  • 33. Observations with captopril (Tensiomin) treatment in hypertensive patients (one-year period).
    Bányai T, Gyimesi A, Pocsay G, Iványi J.
    Ther Hung; 1989 Jan 20; 37(3):144-50. PubMed ID: 2686089
    [Abstract] [Full Text] [Related]

  • 34. Effects of captopril on the development of tolerance to guanethidine.
    Rankin GO, Haas GJ.
    Fed Proc; 1984 Apr 20; 43(5):1342-5. PubMed ID: 6323227
    [Abstract] [Full Text] [Related]

  • 35. Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction.
    Wauters JP, Waeber B, Brunner HR, Guignard JP, Turini GA, Gavras H.
    Clin Nephrol; 1981 Aug 20; 16(2):86-92. PubMed ID: 6266727
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin inhibitors for hypertension.
    Gavras H, Gavras I, Brunner HR.
    Compr Ther; 1980 May 20; 6(5):14-8. PubMed ID: 6155240
    [Abstract] [Full Text] [Related]

  • 37. Clinical studies with captopril treatment of hypertensive patients.
    Varga K, Alföldi S, Kiss I, Simkó K, Farsang C.
    Acta Physiol Hung; 1988 May 20; 72 Suppl():67-78. PubMed ID: 2855293
    [Abstract] [Full Text] [Related]

  • 38. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A, Kechrid C, Larabi M, Belkahia C, Ben Ayed H.
    Nouv Presse Med; 1981 Apr 30; 10(19):1575-8. PubMed ID: 7025848
    [Abstract] [Full Text] [Related]

  • 39. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E, Rosenthal T, Stern N, Knecht A, Yaron A.
    Isr J Med Sci; 1982 May 30; 18(5):597-602. PubMed ID: 6284678
    [Abstract] [Full Text] [Related]

  • 40. Effects of single dose administration of angiotension covering enzyme inhibitor (captopril) on blood pressure, plasma renin activity and plasma aldosterone in patients with essential hypertension. A proposal for the captopril test.
    Kodama K, Morotomi Y, Kida O, Higa T, Someya N, Kondo K, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1984 Sep 30; 26(9):1243-9. PubMed ID: 6392644
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.